The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: implications for a role of COX-1
The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: implications for a role of COX-1
Systemic inflammation gives rise to metabolic and behavioural changes, largely mediated by pro-inflammatory cytokines and prostaglandin production (PGE(2)) at the blood-brain barrier. Despite numerous studies, the exact biological pathways that give rise to these changes remains elusive. This study investigated the mechanisms underlying immune-to-brain communication following systemic inflammation using various anti-inflammatory agents. Mice were pre-treated with selective cyclo-oxygenase (COX) inhibitors, thromboxane synthase inhibitors or dexamethasone, followed by intra-peritoneal injection of lipopolysaccharide (LPS). Changes in body temperature, open-field activity, and burrowing were assessed and mRNA and/or protein levels of inflammatory mediators measured in serum and brain. LPS-induced systemic inflammation resulted in behavioural changes and increased production of IL-6, IL-1beta and TNF-alpha, as well as PGE(2) in serum and brain. Indomethacin and ibuprofen reversed the effect of LPS on behaviour without changing peripheral or central IL-6, IL-1beta and TNF-alpha mRNA levels. In contrast, dexamethasone did not alter LPS-induced behavioural changes, despite complete inhibition of cytokine production. A selective COX-1 inhibitor, piroxicam, but not the selective COX-2 inhibitor, nimesulide, reversed the LPS-induced behavioural changes without affecting IL-6, IL-1beta and TNF-alpha protein expression levels in the periphery or mRNA levels in the hippocampus. Our results suggest that the acute LPS-induced changes in burrowing and open-field activity depend on COX-1. We further show that COX-1 is not responsible for the induction of brain IL-6, IL-1beta and TNF-alpha synthesis or LPS-induced hypothermia. Our results may have implications for novel therapeutic strategies to treat or prevent neurological diseases with an inflammatory component.
cytokines, behaviour, systemic inflammation, indomethacin, COX-1, COX-2
409-419
Teeling, J.L.
fcde1c8e-e5f8-4747-9f3a-6bdb5cd87d0a
Cunningham, C.
6d675038-a4b1-46e2-9e4b-0a5ac27ea2b2
Newman, Tracey A.
322290cb-2e9c-445d-a047-00b1bea39a25
Perry, V.H.
8f29d36a-8e1f-4082-8700-09483bbaeae4
March 2010
Teeling, J.L.
fcde1c8e-e5f8-4747-9f3a-6bdb5cd87d0a
Cunningham, C.
6d675038-a4b1-46e2-9e4b-0a5ac27ea2b2
Newman, Tracey A.
322290cb-2e9c-445d-a047-00b1bea39a25
Perry, V.H.
8f29d36a-8e1f-4082-8700-09483bbaeae4
Teeling, J.L., Cunningham, C., Newman, Tracey A. and Perry, V.H.
(2010)
The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: implications for a role of COX-1.
Brain, Behavior and Immunity, 24 (3), .
(doi:10.1016/j.bbi.2009.11.006).
(PMID:19931610)
Abstract
Systemic inflammation gives rise to metabolic and behavioural changes, largely mediated by pro-inflammatory cytokines and prostaglandin production (PGE(2)) at the blood-brain barrier. Despite numerous studies, the exact biological pathways that give rise to these changes remains elusive. This study investigated the mechanisms underlying immune-to-brain communication following systemic inflammation using various anti-inflammatory agents. Mice were pre-treated with selective cyclo-oxygenase (COX) inhibitors, thromboxane synthase inhibitors or dexamethasone, followed by intra-peritoneal injection of lipopolysaccharide (LPS). Changes in body temperature, open-field activity, and burrowing were assessed and mRNA and/or protein levels of inflammatory mediators measured in serum and brain. LPS-induced systemic inflammation resulted in behavioural changes and increased production of IL-6, IL-1beta and TNF-alpha, as well as PGE(2) in serum and brain. Indomethacin and ibuprofen reversed the effect of LPS on behaviour without changing peripheral or central IL-6, IL-1beta and TNF-alpha mRNA levels. In contrast, dexamethasone did not alter LPS-induced behavioural changes, despite complete inhibition of cytokine production. A selective COX-1 inhibitor, piroxicam, but not the selective COX-2 inhibitor, nimesulide, reversed the LPS-induced behavioural changes without affecting IL-6, IL-1beta and TNF-alpha protein expression levels in the periphery or mRNA levels in the hippocampus. Our results suggest that the acute LPS-induced changes in burrowing and open-field activity depend on COX-1. We further show that COX-1 is not responsible for the induction of brain IL-6, IL-1beta and TNF-alpha synthesis or LPS-induced hypothermia. Our results may have implications for novel therapeutic strategies to treat or prevent neurological diseases with an inflammatory component.
This record has no associated files available for download.
More information
e-pub ahead of print date: 19 November 2009
Published date: March 2010
Keywords:
cytokines, behaviour, systemic inflammation, indomethacin, COX-1, COX-2
Organisations:
Clinical & Experimental Sciences
Identifiers
Local EPrints ID: 338832
URI: http://eprints.soton.ac.uk/id/eprint/338832
ISSN: 0889-1591
PURE UUID: 049f063c-d3f4-4276-abcb-fc27605771d4
Catalogue record
Date deposited: 17 May 2012 14:21
Last modified: 15 Mar 2024 03:21
Export record
Altmetrics
Contributors
Author:
C. Cunningham
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics